Online citations, reference lists, and bibliographies.

Cytoreduction And Intraperitoneal Chemotherapy For The Management Of Peritoneal Carcinomatosis, Sarcomatosis And Mesothelioma.

G. Begossi, S. González-Moreno, G. Ortega-Pérez, L. Fon, P. Sugarbaker
Published 2002 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Despite new developments in multi-modality treatments, complete resection remains as an absolute requirement for cure of gastrointestinal cancer. We have reported benefits from combined treatment with complete cytoreduction and intraperitoneal chemotherapy. This has been achieved with low morbidity and mortality. Success in the surgical management of peritoneal surface malignancy depends on the surgeon's ability to complete complex cytoreductive procedures so that only microscopic residual disease remains. This paper describes the current strategy that the surgical oncologist should pursue in the treatment of patients with peritoneal carcinomatosis, sarcomatosis and mesothelioma. Technical details required for this surgery include patient position, incision and exposure, complete lysis of adhesion, electroevaporative dissection with irrigation and suction to preserve the translucent quality of tissues, peritonectomy procedures, proper positioning of tubes and drains for intraperitoneal chemotherapy, and reconstructive surgery. Understanding the treatment and mastery of surgical skills to manage the peritoneal surface spread of cancer has led to long-term survival of selected patients. Combination of this treatment strategy with proper patient selection has reduced the mortality and morbidity. The success of cytoreductive surgery and perioperative intraperitoneal chemotherapy depends on a long-term dedication to achieve the full potential of a curative outcome. Our unit has continued to achieve good results over two decades as improved results of treatment have evolved.
This paper references
Improved mortality K. Tumor cells in blood shed from the surgical field. Arch Surg rate of gastric carcinoma patients with peritoneal carcinomatosis
E Hansen (1995)
Prognostic significance of serosal invasion in carcinoma of the stomach.
M. Haraguchi (1991)
10.1002/1097-0142(19920815)70:4<737::AID-CNCR2820700404>3.0.CO;2-S
Serosal cytologic study to determine free mesothelial penetration of intraperitoneal colon cancer
Z. Zeng (1992)
10.1001/archsurg.1995.01430040049007
Tumor cells in blood shed from the surgical field.
E. Hansen (1995)
10.1007/978-1-4613-1247-5
Peritoneal Carcinomatosis: Principles of Management
P. Sugarbaker (1996)
10.1002/1097-0142(197910)44:4<1476::AID-CNCR2820440442>3.0.CO;2-R
Intraperitoneal free cancer cells and their viability in gastric cancer
Y. Iitsuka (1979)
10.1016/S0039-6060(96)80145-0
Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination.
Y. Yonemura (1996)
10.1007/978-1-4613-1245-1_3
Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and sarcomatosis.
A. D. Stephens (1996)
10.1002/(SICI)1097-0142(19970301)79:5<884::AID-CNCR3>3.0.CO;2-C
Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery
S. Fujimoto (1997)
Mechanism of abdominal wall recurrence following Accepted for publication
RS Savalgi (2001)
Intraperitoneal chemotherapy for malignant diseases of the gastrointestinal tract.
M. Markman (1987)
Pattern of failure followingstrategy for the management of patients with peritoneal treatment of pseudomyxoma peritonei of appendiceal origin . Eur carcinomatosis , sarcomatosis and mesothelioma
Zoetmulder FAN (1996)
10.1007/978-1-4613-1245-1_6
Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin C.
V. Fernandez-Trigo (1996)
10.1007/978-1-4613-1247-5_24
Laser-mode electrosurgery.
P. Sugarbaker (1996)
Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis.
A. C. Sayag-Beaujard (1999)
10.1007/BF00402474
Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients
S. Koga (1984)
10.1159/000227211
Study of the pharmacokinetics of mitomycin C in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues.
G. Panteix (1993)
10.1007/s10434-999-0790-0
Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique
A. D. Stephens (1999)
10.1002/jso.2930530313
Inadvertent spread of cancer at surgery.
J. Fortner (1993)
10.1007/s002800051093
Successful management of microscopic residual disease in large bowel cancer
P. Sugarbaker (1999)
10.1016/0959-8049(96)00178-5
Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin.
F. Zoetmulder (1996)
Rectal Cancer Trial. Improved survival with preoperative and hyperthermic antiblastic perfusion in the treatment of radiotherapy in resectable rectal cancer
M. Markman (1999)
10.7326/0003-4819-97-6-845
Intraperitoneal cisplatin with systemic thiosulfate protection.
S. Howell (1982)
Potentiation of i.p. chemotherapy
H Baba (1992)
10.1016/S0001-2092(06)63122-0
Hyperthermic intraoperative intraperitoneal chemotherapy safety considerations.
S. K. White (1996)
Effects of intraoperativedetermine free mesothelial penetration of intraperitoneal colon chemo - hyperthermia in patients with gastric cancer with peritonealcancer
Z Zeng (1992)
10.1053/EJSO.1999.0927
Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
F. Cavaliere (2000)
10.1002/1097-0142(19891215)64:12<2482::AID-CNCR2820641213>3.0.CO;2-1
Width of serosal invasion and prognosis in advanced human gastric cancer with special reference to the mode of tumor invasion
H. Baba (1989)
Prognostic significance of serosal invasion in intraperitoneal chemohyperthermia with special mention of thecarcinoma of the stomach
G Panteix (1991)
Serosal cytological study
Z Zeng (1992)
[Elective surgery in recurrent colon cancer with peritoneal seeding: when to and when not to proceed].
J. Esquivel (1999)
Local recurrence of colorectal cancer : hyperthermic intraoperative intraperitoneal chemotherapy usingthe problem , mechanisms , management and adjuvant therapy . Br J the Coliseum technique
AD Stephens (1999)
Phase I andonly no palliative effort . Advances in cytoreductive pharmacologic studies with early postoperative intraperitonealsurgery and perioperative intraperitoneal chemotherapy epiadriamycin
PH Sugarbaker (1989)
[A case of peritoneal malignant mesothelioma with disappearance of ascites result of intraperitoneal instillation of mitomycin C and oral administration of UFT].
T. Hayashi (1989)
10.1007/BF00685503
Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy
G. Los (2004)
10.1056/NEJM199704033361402
Improved survival with preoperative radiotherapy in resectable rectal cancer.
B. Cedermark (1997)
carboplatin and cisplatin into rat peritoneal tumor nodules after Prognostic significance of intraperitoneal free cancer cells in gastric intraperitoneal chemotherapy
S Koga (1991)
Viability of intraperitoneal free cancer cells in patients with gastric cancer.
O. Tanida (1982)
Intraperitoneal chemotherapy in the management of colon cancer.
M. Markman (1999)
10.1002/bjs.1800810106
Local recurrence of colorectal cancer: The problem, mechanisms, management and adjuvant therapy
A. Abulafi (1994)
10.1007/BF02552962
Tumor recurrence in the abdominal wall scar tissue after large-bowel cancer surgery
E. S. R. Hughes (1983)
Intraperitoneal combined surgery
Y Izuka (1997)
Koga S. with peritoneal carcinomatosis
O Tanida (1999)



This paper is referenced by
10.1245/s10434-016-5176-5
Evaluating the Impact of Total Intravenous Anesthesia on the Clinical Outcomes and Perioperative NLR and PLR Profiles of Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
P. Owusu-Agyemang (2016)
10.1016/B978-0-7216-3740-2.50011-X
MRI of the Retroperitoneum and Peritoneum
D. Torigian (2005)
10.1007/2-287-30921-7_25
La chimiothérapie intrapéritonéale avec hyperthermie
O. Gléhen (2006)
10.1245/s10434-007-9700-5
Swedish Experience with Peritonectomy and HIPEC. HIPEC in Peritoneal Carcinomatosis
PhD B. L. van Leeuwen MD (2007)
10.1016/j.ejso.2020.01.020
Cost analysis of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and the risk factors for their increased cost in a public insurance health care system - Single centre study.
Dušan Klos (2020)
10.1007/S12094-007-0118-0
Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals
F. C. Muñoz-Casares (2007)
10.1016/J.EJSO.2004.01.017
The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer.
C. P. Carmignani (2004)
Manejo anestésico de 20 pacientes programados para peritonectomía y quimioterapia intraperitoneal caliente
J. Pérez (2006)
10.1002/JSO.20296
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma.
Samuel P Jacks (2005)
10.1016/j.canrad.2008.05.002
[Hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis arising from gastric cancer].
E. Cotte (2008)
10.1016/S1155-1968(10)53974-9
Traitement des pathologies tumorales du péritoine
Dominique Elias (2010)
10.1016/J.EJSO.2004.02.002
Cytoreductive surgery plus intraperitoneal hyperthermic perfusion is an effective treatment for metastasized malignant mixed mesodermal tumours (MMMT)--report of six cases.
H. Müller (2004)
10.1111/j.1524-4733.2007.00249.x
Cost-effectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancer.
J. Bonastre (2008)
10.1007/978-3-030-38092-2_21
The Role of Near-Infrared Fluorescence Imaging in the Assessment of Peritoneal Carcinomatosis from Colorectal Cancer
Gennaro Galizia (2020)
10.1053/EJSO.2002.1380
Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer.
A. Tentes (2003)
10.1007/s00268-017-4237-7
Fluorescence-Guided Surgery in the Combined Treatment of Peritoneal Carcinomatosis from Colorectal Cancer: Preliminary Results and Considerations
E. Lieto (2017)
10.3748/WJG.V12.I38.6124
Management of pseudomyxoma peritonei.
Zhi-Bo Qu (2006)
10.1016/J.EJSO.2007.02.027
Evaluation of the risk of contamination of surgical personnel by vaporization of oxaliplatin during the intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC).
M. Guerbet (2007)
Morbi-mortalité précoce après chimiothérapie hyperthermique intra-péritonéale au Centre Hospitalo-Universitaire de Rouen : étude prospective
Laure Blampied (2016)
10.1245/s10434-006-9044-6
Lymphatic Drainage of the Peritoneal Space: A Pattern Dependent on Bowel Lymphatics
C. Parungo (2006)
10.1016/J.EJSO.2006.05.011
Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin C.
K. Schmid (2006)
Peritoneal Carcinomatosis from Colorectal Cancer: Fluorescence-Guided Surgery with Indocyanine Green
Annamaria Auricchio (2019)
10.1016/j.ejso.2016.06.389
Intraoperative Near-Infrared Fluorescence Imaging using indocyanine green in colorectal carcinomatosis surgery: Proof of concept.
G. Barabino (2016)
10.1016/J.CANRAD.2008.05.002
Chimiohyperthermie intrapéritonéale dans le traitement des carcinoses péritonéales d’origine gastrique
E. Cotte (2008)
HYPERTHERMIA IN CANCER TREATMENT : A PRIMER Medical Intelligence Unit
Gian Franco Baronzio (2013)
10.1177/030089161009600306
Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Antonios-Apostolos K Tentes (2010)
10.1111/j.1445-2197.2006.03579.x
REVIEW OF PATIENTS WITH PERITONEAL MALIGNANCY TREATED WITH PERITONECTOMY AND HEATED INTRAPERITONEAL CHEMOTHERAPY
R. Hadi (2006)
10.1016/S1055-3207(03)00050-4
Intraperitoneal chemotherapy with mitoxantrone in malignant ascites.
K. Link (2003)
10.1016/J.SOC.2007.04.010
Hepatectomy for colorectal metastases in the presence of extrahepatic disease.
D. Jaeck (2007)
10.1016/J.REVMED.2005.08.017
Nouveautés thérapeutiques dans la prise en charge des carcinoses péritonéales d'origine digestive : chirurgie de cytoréduction et chimiothérapie intrapéritonéale
O. Glehen (2006)
10.1007/978-3-319-15678-1_37
Miniaturized Clinical Imaging Device for Optical Surgery
Paul Dorval (2015)
10.1093/chromsci/bmu095
Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination.
Clayton B'hymer (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar